Daniel J. Lovell

Active 1987–2025

Also published as
Daniel J Lovell
107
Papers
19,995
Citations
76
h-index
104
i10-index

Citations

Citations per year for Daniel J. Lovell1991: 3 citations1992: 1 citations1994: 2 citations1995: 4 citations1996: 2 citations1997: 6 citations1998: 5 citations1999: 12 citations2000: 25 citations2001: 18 citations2002: 41 citations2003: 66 citations2004: 54 citations2005: 95 citations2006: 67 citations2007: 84 citations2008: 79 citations2009: 108 citations2010: 161 citations2011: 165 citations2012: 138 citations2013: 127 citations2014: 164 citations2015: 152 citations2016: 152 citations2017: 127 citations2018: 157 citations2019: 593 citations2020: 568 citations2021: 622 citations2022: 437 citations2023: 287 citations2024: 556 citations2025: 115 citations2026: 6 citations1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,274 citing papers, 20.7% of this breakdownUnited Kingdom: 500 citing papers, 8.1% of this breakdownItaly: 481 citing papers, 7.8% of this breakdownCanada: 375 citing papers, 6.1% of this breakdownGermany: 370 citing papers, 6% of this breakdownNetherlands: 261 citing papers, 4.2% of this breakdownChina: 245 citing papers, 4% of this breakdownFrance: 245 citing papers, 4% of this breakdownSpain: 152 citing papers, 2.5% of this breakdownJapan: 148 citing papers, 2.4% of this breakdownSwitzerland: 136 citing papers, 2.2% of this breakdownTürkiye: 126 citing papers, 2.1% of this breakdown
0%20.7%Other 29.9%

Fields

  • Medicine73.7%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology6.4%
  • Health Professions1%
  • Social Sciences0.5%
  • Neuroscience0.3%
  • Other1%

Topics

  • Autoimmune and Inflammatory Disorders Research16.4%
  • Rheumatoid Arthritis Research and Therapies6.8%
  • Inflammasome and immune disorders6.6%
  • Adolescent and Pediatric Healthcare4.9%
  • Spondyloarthritis Studies and Treatments3%
  • Systemic Lupus Erythematosus Research2.9%
  • Other59.4%

Coauthors

All papers

Open in search
  1. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nico Wulffraat, Erkan Demirkaya, Hermine I. Brunner, Alberto Martini, Nicolino Ruperto, Randy Q. Cron - Arthritis & Rheumatology 2015 cited by 771

  2. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    Authors: , , , , , , , , , , , , , , - The Journal of Rheumatology 2018 cited by 546

  3. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Irina Lazariciu, Ming-Ann Hsu, Ricardo M Suehiro, Alberto Martini, Daniel J Lovell, R Cuttica, J Akikusa, J Chaitow, C Wouters, S Oliveira, CLS Neiva, M Santiago, CA Silva, MT Terreri, C Magalhaes, V De Souza, M Bandeira, G Chédeville, K Houghton, M Vazquez-Del Mercado, J Rizo Rodriguez, K Kobusinska, E Alexeeva, I Calvo Penades, AL Boteanu, O Kasapcopur, MH Poyrazoglu, M Erguven, S Ozen, E Al-Abadi, J Bohnsack, R Carrasco, J Dare, B Gottlieb, D Wahezi, L Jung, M Klein-Gitelman, Y Zhang, L Wagner-Weiner, S Tarvin, RK Vehe, P Chiraseveenuprapund, R Rivas-Chacon, W De La Pena, ACP Sagcal-Gironella, JE Weiss - The Lancet 2021 cited by 187

  4. Juvenile idiopathic arthritis

    Authors: , , , , , , - Nature Reviews Disease Primers 2022 cited by 281

  5. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 873

  6. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 481

  7. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nico Wulffraat, Erkan Demirkaya, Hermine I. Brunner, Alberto Martini, Nicolino Ruperto, Randy Q. Cron - Annals of the Rheumatic Diseases 2016 cited by 397

  8. Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 193

  9. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Flávio Sztajnbok, K. Lheritier, Kenneth Abrams, Dennis Kim, Alberto Martini, Daniel J. Lovell - New England Journal of Medicine 2012 cited by 709

  10. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James Reston - Arthritis & Rheumatology 2022 cited by 231

  11. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 310

  12. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yahya Aghighi, Maya-Feriel Aiche, Constantin Ailioaie, Nuray Aktay Ayaz, Safiya Al‐Abrawi, Е.I. Alexeeva, Jordi Antón, Adriana Apostol, O Arguedas, Tadej Avčin, Patrizia Barone, Lillemor Berntson, Alina Boteanu, Yaryna Boyko, Rubén Burgos‐Vargas, Inmaculada Calvo Penadés, Gaëlle Chédeville, Rolando Cimaz, Adele Civino, Rita Consolini, Tamás Constantin, Rubén Cuttica, Tomas Dallos, Neil A. Martin, Silvia Magni‐Manzoni, Carmen De Cunto, Pavla Doležalová, Maria Ekelund, Yasser El Miedany, Graciela Espada, Anne Estmann Christensen, Ivan Foeldvari, Romina Gallizzi, Gerd Ganser, V. Gerloni, Johannes‐Peter Haas, Liora Harel, Miroslav Harjaček, Soad Hashad, Troels Herlin, Cristina Herrera, Michaël Hofer, Dirk Holzinger, Gerd Horneff, Hans-Iko Huppertz, N Iagăru, Amparo Ibanez Estrella, Maka Ioseliani, Rik Joos, Sheila Knupp Feitosa de Oliveira, Sylvia Kamphuis, Özgür Kasapçopur, María Martha Katsicas, Raju Khubchandani, Anuela Kondi, Liisa Kröger, Francesco La Torre, Matilda Láday, Pekka Lahdenne, Maria Cristina Maggio, Maria Greca Magnolia, Clara Malagón, Merja Malin, Silvana Martino, José Melo‐Gomes, Pablo Mesa-del-Castillo, Andrea Militaru, Kirsten Minden, Angela Miniaci, Mohammad Hasan Moradinejad and 40 more - The Lancet Child & Adolescent Health 2019 cited by 214

  13. Treating juvenile idiopathic arthritis to target: recommendations of an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Josef S Smolen - Annals of the Rheumatic Diseases 2018 cited by 357

  14. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 110

  15. Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report

    Authors: , , , , , , , , , , , , , - Diabetes Care 2015 cited by 92

  16. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raphaela Goldbach‐Mansky - Arthritis & Rheumatism 2002 cited by 703

  17. Preliminary definition of improvement in juvenile arthritis

    Authors: , , , , , - Arthritis & Rheumatism 1997 cited by 1,052

  18. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

    Authors: , , , , , , , , , - Arthritis & Rheumatology 2015 cited by 129

  19. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA‐125a‐5p in Polarized Monocyte Phenotypes

    Authors: , , , , , , - Arthritis & Rheumatology 2016 cited by 92

  20. Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 77

  21. New Medications Are Needed for Children With Juvenile Idiopathic Arthritis

    Authors: , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2020 cited by 60

  22. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition

    Authors: , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2019 cited by 118

  23. Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 627

  24. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

    Authors: , , , , , , , , , , , , , , , - Arthritis Care & Research 2010 cited by 272